Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filip van den Bosch

Showing results (111-120 of 193) with videos related to

Pageof 20
Sort By:
Pediatric Rheumatology Online Journal|April 13, 2017
ASAS definition for sacroiliitis on MRI in SpA: applicable to children?Nele Herregods, Joke Dehoorne, Filip Van den Bosch, et al.
Rheumatology (Oxford, England)|October 25, 2022
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 studyAndrew Östör, Filip Van den Bosch, Kim Papp, et al.
Rheumatology (Oxford, England)|December 27, 2022
Ultrasound-guided core needle biopsy and incisional biopsy of the parotid gland are comparable in diagnosis of primary Sjögren's syndromeLiselotte Deroo, Eva Genbrugge, Frederick Dochy, et al.
Rheumatology (Oxford, England)|July 5, 2022
Anti-CD74 IgA antibodies show diagnostic potential for axial spondyloarthritis but are not associated with microscopic gut inflammationAnn-Sophie De Craemer, Torsten Witte, Triana Lobaton Ortega, et al.
Clinical and Experimental Rheumatology|October 6, 2022
The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB/La reactivities in relation to diagnosis and phenotypes in primary Sjögren's syndromeLiselotte Deroo, Helena Achten, Kristel De Boeck, et al.
Arthritis and Rheumatism|October 1, 2004
Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathyBernard Vandooren, Elli Kruithof, David T Y Yu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 18, 2022
Progressive Increase in Sacroiliac Joint and Spinal Lesions Detected on Magnetic Resonance Imaging in Healthy Individuals in Relation to AgeThomas Renson, Manouk de Hooge, Ann-Sophie De Craemer, et al.
Clinical and Experimental Rheumatology|July 5, 2023
Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 studyPhilip Mease, Arathi Setty, Kim Papp, et al.
Lancet (London, England)|June 18, 2018
Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trialGerd R Burmester, Joel M Kremer, Filip Van den Bosch, et al.
The Journal of Rheumatology|November 15, 2022
Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV TrialFilip Van den Bosch, James Cheng-Chung Wei, Peter Nash, et al.
Pageof 20

Showing results (111-120 of 193) with videos related to

Sort By:
Pageof 20
Pediatric Rheumatology Online Journal|April 13, 2017
ASAS definition for sacroiliitis on MRI in SpA: applicable to children?Nele Herregods, Joke Dehoorne, Filip Van den Bosch, et al.
Rheumatology (Oxford, England)|October 25, 2022
Efficacy and safety of risankizumab for active psoriatic arthritis: 52-week results from the KEEPsAKE 2 studyAndrew Östör, Filip Van den Bosch, Kim Papp, et al.
Rheumatology (Oxford, England)|December 27, 2022
Ultrasound-guided core needle biopsy and incisional biopsy of the parotid gland are comparable in diagnosis of primary Sjögren's syndromeLiselotte Deroo, Eva Genbrugge, Frederick Dochy, et al.
Rheumatology (Oxford, England)|July 5, 2022
Anti-CD74 IgA antibodies show diagnostic potential for axial spondyloarthritis but are not associated with microscopic gut inflammationAnn-Sophie De Craemer, Torsten Witte, Triana Lobaton Ortega, et al.
Clinical and Experimental Rheumatology|October 6, 2022
The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB/La reactivities in relation to diagnosis and phenotypes in primary Sjögren's syndromeLiselotte Deroo, Helena Achten, Kristel De Boeck, et al.
Arthritis and Rheumatism|October 1, 2004
Involvement of matrix metalloproteinases and their inhibitors in peripheral synovitis and down-regulation by tumor necrosis factor alpha blockade in spondylarthropathyBernard Vandooren, Elli Kruithof, David T Y Yu, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 18, 2022
Progressive Increase in Sacroiliac Joint and Spinal Lesions Detected on Magnetic Resonance Imaging in Healthy Individuals in Relation to AgeThomas Renson, Manouk de Hooge, Ann-Sophie De Craemer, et al.
Clinical and Experimental Rheumatology|July 5, 2023
Upadacitinib in patients with psoriatic arthritis and inadequate response to biologics: 3-year results from the open-label extension of the randomised controlled phase 3 SELECT-PsA 2 studyPhilip Mease, Arathi Setty, Kim Papp, et al.
Lancet (London, England)|June 18, 2018
Safety and efficacy of upadacitinib in patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying anti-rheumatic drugs (SELECT-NEXT): a randomised, double-blind, placebo-controlled phase 3 trialGerd R Burmester, Joel M Kremer, Filip Van den Bosch, et al.
The Journal of Rheumatology|November 15, 2022
Etanercept Withdrawal and Retreatment in Nonradiographic Axial Spondyloarthritis: Results of RE-EMBARK, an Open-Label Phase IV TrialFilip Van den Bosch, James Cheng-Chung Wei, Peter Nash, et al.
Pageof 20